Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

RNA Interference

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

RNA Editing

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lentiviral protein delivery of meganucleases in human cells mediates gene targeting and alleviates toxicity.

Gene therapy·2014

Same author

In situ retrovirus-mediated gene transfer into the liver.

Methods in molecular medicine·2014

Same author

Delivery of therapeutic proteins from genetically-modified cells.

Restorative neurology and neuroscience·2011

Same author

Construction of Retro viral Packaging Cell Lines.

Methods in molecular biology (Clifton, N.J.)·2011

Same author

Relevance of an academic GMP Pan-European vector infra-structure (PEVI).

Current gene therapy·2010

Same author

Evaluation of a Serum-free Medium for the Production of rAAV-2 using HeLa Derived Producer Cells.

Cytotechnology·2008

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Production and Titering of Recombinant Adeno-associated Viral Vectors

Production and Titering of Recombinant Adeno-associated Viral Vectors

Published on: November 27, 2011

AAV vectors for RNA-based modulation of gene expression.

¹Inserm U781, Hôpital Necker-Enfants Malades & Université Paris Descartes, Paris, France. olivier.danos@necker.fr

|April 18, 2008

Summary

Gene expression regulation involves intricate molecular machines. Adeno-associated virus technology enables non-coding RNA expression for functional genomics and therapeutic strategies.

Area of Science:

Molecular Biology
Genetics
Biotechnology

Background:

Gene expression is regulated post-transcriptionally by molecular machines controlling RNA processing, transport, translation, and degradation.
These processes rely on nucleoprotein complexes recognizing specific RNA sequence motifs.
Targeting these motifs with complementary RNA sequences can alter cell phenotype or correct mutations.

Purpose of the Study:

To review the application of adeno-associated virus (AAV) technology for expressing non-coding RNAs.
To explore the use of AAV-mediated non-coding RNA expression in functional genomic studies.
To discuss the potential of AAV technology in developing novel therapeutic strategies.

Main Methods:

Utilizing adeno-associated virus vectors for efficient gene delivery.

More Related Videos

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts

Published on: December 17, 2016

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Published on: October 18, 2022

Related Experiment Videos

Last Updated: Jul 5, 2026

Production and Titering of Recombinant Adeno-associated Viral Vectors

Production and Titering of Recombinant Adeno-associated Viral Vectors

Published on: November 27, 2011

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts

Published on: December 17, 2016

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Published on: October 18, 2022

Expressing non-coding RNAs to modulate gene expression at the post-transcriptional level.

Employing Watson-Crick base pairing to mask target RNA sequences.

Main Results:

Adeno-associated virus technology is effective for expressing non-coding RNAs in various tissues, including the brain, muscle, and liver.
This approach allows for precise manipulation of cellular phenotypes.
It offers a method to compensate for the detrimental effects of genetic mutations.

Conclusions:

Adeno-associated virus technology is a versatile tool for functional genomics and therapeutic development.
Non-coding RNA expression via AAV provides a powerful strategy for gene regulation.
This technology holds significant promise for treating genetic disorders.